{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:11:47Z","timestamp":1786122707088,"version":"build-2736575974"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Breast cancer remains the most frequently diagnosed malignancy and a leading cause of cancer-related mortality among women worldwide. While immune checkpoint inhibitors have transformed treatment for a subset of patients, durable responses remain limited, in part because the tumor immune microenvironment is profoundly shaped by age-associated immune decline\u2014termed immunosenescence. In this review, we critically synthesize how tumor immunosenescence may contribute to breast cancer progression and therapeutic resistance, distinguishing correlative observations from mechanistically established relationships. We examine T cell senescence and exhaustion as mechanistically separable states with distinct therapeutic implications, and evaluate the roles of cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs) as orchestrators of immunosenescence through SASP production, immune exclusion, and metabolic remodeling. We discuss subtype-specific immunosenescence signatures (TNBC, HER2+, HR+), hormonal and menopausal influences, stage-dependent immune alterations, and BRCA-associated susceptibility. The senescence-associated secretory phenotype (SASP)\u2014comprising IL-6, IL-8, TGF-\u03b2, and matrix metalloproteinases\u2014serves as a central mediator linking cellular senescence to immune evasion and metastatic dissemination, though much of the evidence derives from preclinical models. Therapy-induced senescence following chemotherapy and radiotherapy may paradoxically drive relapse through SASP-mediated immunomodulation, a hypothesis that lacks prospective clinical validation. We review clinical evidence that aging is associated with diminished interferon signaling, reduced tumor-infiltrating lymphocyte density, and altered checkpoint blockade efficacy in some but not all studies, acknowledging substantial inter-patient heterogeneity. We highlight recent advances in single-cell and spatial profiling technologies and discuss challenges in biomarker standardization and clinical implementation. Finally, we evaluate emerging interventions\u2014senolytics (navitoclax, dasatinib plus quercetin, fisetin), senomorphics, metabolic rescue via NAD+ repletion, STING agonists, and rational senotherapy-immunotherapy combinations\u2014emphasizing that most remain at preclinical or early clinical stages. We conclude that targeting tumor immunosenescence represents a promising but incompletely validated therapeutic axis for enhancing anti-tumor immunity in breast cancer.<\/jats:p>","DOI":"10.3389\/fonc.2026.1912627","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T12:18:59Z","timestamp":1786105139000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor immunosenescence drives breast cancer progression and therapeutic resistance: mechanisms and emerging interventions"],"prefix":"10.3389","volume":"16","author":[{"given":"Qingran","family":"Lei","sequence":"first","affiliation":[{"name":"Department of Breast and Thyroid Surgery, First People\u2019s Hospital of Kunming City & Calmette Affiliated Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, First People\u2019s Hospital of Kunming City & Calmette Affiliated Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13045-020-00986-z","article-title":"Immunosenescence: a key player in cancer development","volume":"13","author":"Lian","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-017-0006-x","article-title":"The twilight of immunity: emerging concepts in aging of the immune system","volume":"19","author":"Nikolich-\u017dugich","year":"2018","journal-title":"Nat Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adj7808","article-title":"Interferon-induced senescent CD8+ T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer","volume":"17","author":"Fu","year":"2025","journal-title":"Sci Transl Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-18-1454","article-title":"Interferon signaling is diminished with age and is associated with immune checkpoint blockade efficacy in triple-negative breast cancer","volume":"9","author":"Sceneay","year":"2019","journal-title":"Cancer Discov"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124716","article-title":"Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging","volume":"5","author":"Mu\u00f1oz","year":"2019","journal-title":"JCI Insight"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00450-9","article-title":"Exploiting senescence for the treatment of cancer","volume":"22","author":"Wang","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2009.00489.x","article-title":"Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging","volume":"8","author":"Liu","year":"2009","journal-title":"Aging Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41423-019-0344-8","article-title":"Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment","volume":"17","author":"Zhao","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2174\/1871520621666210618100857","article-title":"Single-cell transcriptome analysis reveals the M2 macrophages and exhausted T cells and intratumoral heterogeneity in triple-negative breast cancer","volume":"22","author":"Xu","year":"2022","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6802","article-title":"Immune checkpoint status and exhaustion-related phenotypes of CD8+ T cells from the tumor-draining regional lymph nodes in breast cancer","volume":"12","author":"Yilmaz","year":"2023","journal-title":"Cancer Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00927-z","article-title":"Hallmarks of T cell aging","volume":"22","author":"Mittelbrunn","year":"2021","journal-title":"Nat Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2020.07.004","article-title":"Homeostasis and the functional roles of CD4+ Treg cells in aging","volume":"226","author":"Churov","year":"2020","journal-title":"Immunol Lett"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.106087","article-title":"Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target","volume":"78","author":"Hashemi","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adr7934","article-title":"CD4+FOXP3Exon2+ regulatory T cell frequency predicts breast cancer prognosis and survival","volume":"11","author":"Fusco","year":"2025","journal-title":"Sci Adv"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3233\/bd-239002","article-title":"FOXP3+ regulatory T cells on prognosis of breast cancer","volume":"42","author":"Usman","year":"2023","journal-title":"Breast Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1172\/jci45816","article-title":"Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity","volume":"121","author":"Mamessier","year":"2011","journal-title":"J Clin Invest"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9972927","article-title":"Natural killer cell dysfunction in obese patients with breast cancer: a review of a triad and its implications","volume":"2021","author":"Elaraby","year":"2021","journal-title":"J Immunol Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00049","article-title":"Characterizing the dysfunctional NK cell: assessing the clinical relevance of exhaustion, anergy, and senescence","volume":"10","author":"Judge","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116224","article-title":"Guardians and mediators of metastasis: exploring T lymphocytes, myeloid-derived suppressor cells, and tumor-associated macrophages in the breast cancer microenvironment","volume":"25","author":"Ruocco","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2017.03.008","article-title":"Aging and cancer: the role of macrophages and neutrophils","volume":"36","author":"Jackaman","year":"2017","journal-title":"Ageing Res Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1050484","DOI":"10.3389\/fimmu.2022.1050484","article-title":"The effects of dendritic cell-based vaccines in the tumor microenvironment: impact on myeloid-derived suppressor cells","volume":"13","author":"S\u00e1nchez-Le\u00f3n","year":"2022","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7150\/thno.105423","article-title":"B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications","volume":"15","author":"Wu","year":"2025","journal-title":"Theranostics"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2026.101004","article-title":"Mature tertiary lymphoid structures in breast cancers are associated with anti-tumor immunity and better prognosis","volume":"39","author":"Yu","year":"2026","journal-title":"Mod Pathol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1346","article-title":"Single-cell transcriptome sequencing of B-cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy","volume":"13","author":"Wang","year":"2023","journal-title":"Clin Transl Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00773","article-title":"Thymic function associated with cancer development, relapse, and antitumor immunity\u2014a mini-review","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1714478115","article-title":"Thymic involution and rising disease incidence with age","volume":"115","author":"Palmer","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0156-2","article-title":"Unmasking senescence: context-dependent effects of SASP in cancer","volume":"19","author":"Faget","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102209","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression","volume":"5","author":"Copp\u00e9","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12894","article-title":"Cellular senescence and cancer: focusing on traditional Chinese medicine and natural products","volume":"53","author":"Liu","year":"2020","journal-title":"Cell Prolif"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-23-0051","article-title":"Senescence and immunotherapy: redundant immunomodulatory pathways promote resistance","volume":"11","author":"Oesterreich","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104922","article-title":"A role for fibroblast-derived SASP factors in the activation of pyroptotic cell death in mammary epithelial cells","volume":"299","author":"Hom","year":"2023","journal-title":"J Biol Chem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040822","article-title":"Therapy-induced senescence: an \u201cold\u201d friend becomes the enemy","volume":"12","author":"Saleh","year":"2020","journal-title":"Cancers"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11113066","article-title":"The combination of radiation with PARP inhibition enhances senescence and sensitivity to the senolytic, navitoclax, in triple negative breast tumor cells","volume":"11","author":"Softah","year":"2023","journal-title":"Biomedicines"},{"key":"B39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s44446-025-00034-2","article-title":"Talazoparib and radiation enhance the senolytic efficacy of venetoclax in therapy-induced senescent triple-negative breast cancer cells","volume":"33","author":"Almudimeegh","year":"2025","journal-title":"Saudi Pharm J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/s1470-2045(17)30904-x","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12957-022-02513-5","article-title":"Differences in tumor-infiltrating lymphocyte density and prognostic factors for breast cancer by patient age","volume":"20","author":"Takada","year":"2022","journal-title":"World J Surg Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-25-0948","article-title":"Association of tumor-infiltrating lymphocyte subtypes with clinical characteristics and prognosis in young women with hormone receptor-positive breast cancer","author":"Tesch","year":"2025","journal-title":"Clin Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-25-4035","article-title":"Immunity, age, and luminal breast cancer: understanding the Holy Trinity","author":"Salgado","year":"2025","journal-title":"Clin Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1809615","article-title":"Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1053\/j.seminoncol.2018.08.006","article-title":"Aging, immune senescence, and immunotherapy: a comprehensive review","volume":"45","author":"Elias","year":"2018","journal-title":"Semin Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-16-0062","article-title":"Role of telomeres and telomerase in aging and cancer","volume":"6","author":"Shay","year":"2016","journal-title":"Cancer Discov"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01923-y","article-title":"Cellular senescence and senolytics: the path to the clinic","volume":"28","author":"Chaib","year":"2022","journal-title":"Nat Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3823","article-title":"Cellular senescence: from physiology to pathology","volume":"15","author":"Mu\u00f1oz-Esp\u00edn","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2026.1661424","article-title":"Differential responses to the combination of navitoclax and venetoclax with doxorubicin in murine models of triple negative breast cancer","volume":"14","author":"As Sobeai","year":"2026","journal-title":"Front Cell Dev Biol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.64898\/2026.05.20.726695","article-title":"Ferrous iron accumulation is a hallmark and therapeutic vulnerability of therapy-induced senescence","year":"2026","journal-title":"bioRxiv"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.32604\/or.2023.044775","article-title":"Metochalcone induces senescence-associated secretory phenotype via JAK2\/STAT3 pathway in breast cancer","volume":"32","author":"Zhou","year":"2024","journal-title":"Oncol Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.01.012","article-title":"Metabolic programs tailor T cell immunity in viral infection, cancer, and aging","volume":"34","author":"Moller","year":"2022","journal-title":"Cell Metab"},{"key":"B53","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-018-0629-x","article-title":"T cell senescence and CAR-T cell exhaustion in hematological Malignancies","volume":"11","author":"Kasakovski","year":"2018","journal-title":"J Hematol Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1912627\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T12:19:00Z","timestamp":1786105140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1912627\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":53,"alternative-id":["10.3389\/fonc.2026.1912627"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1912627","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"article-number":"1912627"}}